Abstract

ObjectiveTo determine whether highly prevalent P. aeruginosa sequence types (ST) in Dutch cystic fibrosis (CF) patients are specifically linked to CF patients we investigated the population structure of P. aeruginosa from different clinical backgrounds. We first selected the optimal genotyping method by comparing pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST) and multilocus variable number tandem-repeat analysis (MLVA).MethodsSelected P. aeruginosa isolates (n = 60) were genotyped with PFGE, MLST and MLVA to determine the diversity index (DI) and congruence (adjusted Rand and Wallace coefficients). Subsequently, isolates from patients admitted to two different ICUs (n = 205), from CF patients (n = 100) and from non-ICU, non-CF patients (n = 58, of which 19 were community acquired) were genotyped with MLVA to determine distribution of genotypes and genetic diversity.ResultsCongruence between the typing methods was >79% and DIs were similar and all >0.963. Based on costs, ease, speed and possibilities to compare results between labs an adapted MLVA scheme called MLVA9-Utrecht was selected as the preferred typing method. In 363 clinical isolates 252 different MLVA types (MTs) were identified, indicating a highly diverse population (DI = 0.995; CI = 0.993–0.997). DI levels were similarly high in the diverse clinical sources (all >0.981) and only eight genotypes were shared. MTs were highly specific (>80%) for the different patient populations, even for similar patient groups (ICU patients) in two distinct geographic regions, with only three of 142 ICU genotypes detected in both ICUs. The two major CF clones were unique to CF patients.ConclusionThe population structure of P. aeruginosa isolates is highly diverse and population specific without evidence for a core lineage in which major CF, hospital or community clones co-cluster. The two genotypes highly prevalent among Dutch CF patients appeared unique to CF patients, suggesting specific adaptation of these clones to the CF lung.

Highlights

  • Pseudomonas aeruginosa can cause nosocomial infections in immuno-compromised patients and patients in intensive care units (ICUs), and is a major cause of morbidity and mortality in patients with cystic fibrosis (CF) [1]

  • In a previous cross-sectional study, investigating the population structure of respiratory P. aeruginosa isolates among Dutch CF patients by using multilocus sequence typing (MLST), we described two sequence types (ST), ST406 and ST497 in 15% and 5% of all patients infected with P. aeruginosa, respectively [8]

  • In order to determine whether these prevalent STs are linked to patients with CF, or ubiquitously present in other patient populations, we aimed to investigate the genetic relatedness and population structure of P. aeruginosa isolates from CF and non-CF patients

Read more

Summary

Introduction

Pseudomonas aeruginosa can cause nosocomial infections in immuno-compromised patients and patients in intensive care units (ICUs), and is a major cause of morbidity and mortality in patients with cystic fibrosis (CF) [1]. In a previous cross-sectional study, investigating the population structure of respiratory P. aeruginosa isolates among Dutch CF patients by using multilocus sequence typing (MLST), we described two sequence types (ST), ST406 and ST497 in 15% and 5% of all patients infected with P. aeruginosa, respectively [8]. Both STs were not genetically linked to previously described international epidemic clones, which were not detected in this CF population. After identifying the optimal typing scheme, based on discriminatory power, typeability, time, ease of interpretation and of international comparability and costs, we determined the population structure of multiple P. aeruginosa isolates from different epidemiological backgrounds

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.